Pretoria, 23 February 2026 – The South African Health Products Regulatory Authority (SAHPRA) has noted the recent Carte Blanche broadcast raising concerns, based on information from a former employee, regarding alleged Good Manufacturing Practice (GMP) non-compliance at Adcock Ingram’s manufacturing facility in Clayville, Johannesburg. SAHPRA wishes...
Pretoria, 13 February 2026 -The South African Health Products Regulatory Authority (SAHPRA) confirms that it has granted Section 21 authorisation for the importation of the Dollvet Foot and Mouth Disease (FMD) vaccine with conditions and is currently assessing an additional application for the same vaccine. Foot...
For immediate release Pretoria, 8 January 2026 - The South African Health Products Regulatory Authority (SAHPRA) has been made aware of products in the market containing Zinc picolinate (as a source material for zinc) and/or Selenium intended for use in children. Both of these ingredients have been...
Embargo: Immediate release Pretoria, 1 December 2025 – The South African Health Products Regulatory Authority (SAHPRA) has officially been accepted as a member of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), following an ICH assessment of compliance with requirements...
SAHPRA offices will be closed for the festive season from 12:00 on Wednesday, 24 December 2025 and will re-open at 08:00 on Monday, 05 January 2026. Please note: Dates, placed within brackets for various email addresses, will guide stakeholders to the timeframes that emails will be processed. Dates,...
[Embargoed] Johannesburg, 19 November 2025 – As artificial intelligence (AI) increasingly enters the mental health space, from therapy chatbots to diagnostic tools, the world faces a critical question: can AI expand access to care without putting people at risk? At the G20 Social Summit in Johannesburg,...
Pretoria, 11 November 2025 – The South African Health Products Regulatory Authority (SAHPRA) cautions members of the public against purchasing or using GLP-1 (glucagon-like peptide-1) products that are being promoted and sold on various social media platforms. These products are being promoted to assist with...
The South African Health Products Regulatory Authority (SAHPRA) hosted a Regulatory Technical Forum (RTF) Meeting. Areas of discussion on the agenda included: Veterinary Medicines Medical Devices & IVDs Complementary Medicines Medicines (Allopathic) Inspectorate Updates Inspectorate and Regulatory Compliance Legislation/Guidelines for Comment/Implementation IT Upgrade Recording ...
Pretoria, 27 October 2025 – The South African Health Products Regulatory Authority (SAHPRA) is pleased to announce the registration of Lenacapavir. Lenacapavir is an antiviral medicine that is recommended, in combination with safer sex practices, for pre-exposure prophylaxis (PrEP) to prevent HIV-1 infection in adults...
Pretoria, 15 October 2025 – The South African Health Products Regulatory Authority (SAHPRA) and the Health Professions Council of South Africa (HPCSA) signed a Memorandum of Agreement (MOA) on 18 August 2025 for five years. The main objective of this MOA is to enable collaboration...
